Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in Studentbostäder i Sverige AB’s issuance of additional sustainable bonds
Mandate

Vinge advises in Studentbostäder i Sverige AB’s issuance of additional sustainable bonds

December 20, 2021 Banking and Finance

Vinge advises in Studentbostäder i Sverige AB’s (the “Company”) issuance of a additional senior unsecured sustainability bonds in an amount of SEK 100,000,000 within a framework amount of SEK 1,000,000,000 (the “Bonds”).

The proceeds shall be applied in accordance with the Company’s sustainability bond framework, which has been established in accordance with the 2018 ICMA Sustainability Bond Guidelines. The sustainability framework supports, among others, the UN’s global sustainable development goals; no. 7 “affordable and clean energy”, no. 11 “sustainable cities and communities” and no. 13 “climate action”.

In accordance with the terms and conditions, the Bonds are intended to be listed on the sustainable bond list of Nasdaq Stockholm. Arctic Securities acted as bookrunner and arranger in connection with the issuance of the Bonds.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda and Felix Möller.

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025